国际标准期刊号: ISSN:2167-7964

放射学组学杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 打开 J 门
  • Genamics 期刊搜索
  • 研究圣经
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • SWB 在线目录
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • ICMJE
分享此页面

抽象的

Carotid Artery Stenting: A Single-Center Experience of a Tertiary Care Hospital

Refan Alajmi, Riyadh Alokaily

Background: Carotid artery stenting (CASt) is a method of carotid revascularization, which has developed rapidly over the last 3 decades. CASt now used as an alternative to endarterectomise. Although excellent results from centres with high-volume experience seem to demonstrate CASt as technically feasible and safe, there is an on-going debate about the complications in terms of early outcomes in patients.

Methods: This study was a retrospective study on patients diagnosed with carotid artery stenosis (CASs). The data collected from Jan 2011 to Dec 2019. The patient data screened for inclusion in the study based on findings from contrast angiography. Primary complications to be assessed were major or minor embolic stroke, cardiac arrest, and death within 30 days of the procedure. Minor stroke, myocardial infarction, acute hypotension and bradycardia, no cerebral bleeding, access-site bleeding was considered secondary outcomes.

Results: A total of 77 patients were included in the study with a mean age of 74.4 ± 11.3 years. The technical procedure of CASt was 100% successful for all the patients. Overall post-procedural stroke rate at 30 days was 7.7% (six out of 77). One (1.3%) patient died due to cardiac arrest. There were two cases (2.6%) of acute hypotension and Bradycardiac and one case (1.3%) of Access-site bleeding within 30 days of stent implantation. Comorbid conditions were not significantly (p>0.05) associated with the post- procedural complications in CASt.

Conclusion: In this study, we found that CASt is the most reliable technique for CASs and appears feasible and comparatively safe with least post-procedural complications.

However, advanced techniques are required to further reduce the death/stroke rate within 30 days of stent implantation.